Back to Search
Start Over
Back to the basics: Propolis and COVID ‐19
- Source :
- Dermatologic Therapy
- Publication Year :
- 2020
- Publisher :
- Wiley, 2020.
-
Abstract
- The epidemiological burden of COVID-19 is a healthcare challenge throughout the world, not only in terms of testing the limits of medical capacities, but also as an enigma considering preventive strategies and methods. The upper respiratory tract mucosa is the first line of defense, as a physical barrier, as well as through multiple innate and adaptive immune mechanisms which are crucial for efficient antiviral responses. Identifying methods able to reduce or prevent colonization, viral adhesion, and promote virus shedding on mucous membranes or have the ability to inactivate pathogens and thus reduce virus dose and/or increase immune response would be essential in the management of COVID-19 outbreak and help in flattening the curve. We review the effects of propolis, an old remedy with proven antiviral properties, as a possible low-cost inhibitor of SARS-CoV-2 in the oropharyngeal niche, prophylaxis, or adjuvant therapy.
- Subjects :
- Coronavirus disease 2019 (COVID-19)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Pneumonia, Viral
Dermatology
Virus
SARS‐CoV‐2
Propolis
quercetin
Short Papers
030207 dermatology & venereal diseases
03 medical and health sciences
Betacoronavirus
0302 clinical medicine
Immune system
prevention
Anti-Infective Agents
COVID‐19
Adjuvant therapy
Medicine
Short Paper
Humans
Viral shedding
Pandemics
business.industry
SARS-CoV-2
Outbreak
COVID-19
General Medicine
030220 oncology & carcinogenesis
Immunology
business
Coronavirus Infections
Subjects
Details
- Language :
- English
- ISSN :
- 15298019 and 13960296
- Database :
- OpenAIRE
- Journal :
- Dermatologic Therapy
- Accession number :
- edsair.doi.dedup.....d37cfdd7bf44923573e4d0b9f8f68947
- Full Text :
- https://doi.org/10.1111/dth.13780